EURONEXT-PAR$NBTX

Nanobiotix SA · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Headline financials

Total Revenue

€3.29M

Previous: €665K+395.6%
EPS (adj)

-€0.80

Previous: -€0.76-6.0%
Net Income

-€28.1M

Previous: -€26.4M-6.6%
Operating Income

-€25.4M

Previous: -€26.2M+3.3%
Gross Profit

€3.29M

Previous: -€81.5K+4140.5%
R&D Expense

€17.8M

Previous: €15.9M+11.7%

Revenue & EPS history

Nanobiotix SA · Revenue · Quarterly

€3.29M

Q2 2023+395.6%vs Q2 2022
Beat estimate in 1 of 6 quarters(17%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-2.5%

Avg return

Earnings day

-8.7%

Avg return

5 days after

+9.1%

Avg return

30 days after

63%

5 / 8 earnings

Positive

+6.4%

Q2 2024

Best reaction

-31.3%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2024+6.4%-1.4%-5.4%
Q4 2024+3.5%+1.8%+15.6%
Q2 2023-1.5%-4.2%+48.6%
Q4 2022-31.3%-42.8%+33.4%
Q2 2022-5.9%-4.6%+7.0%
Q4 2021+3.8%-5.7%-15.5%
Q2 2021+0.8%-3.8%+3.2%
Q4 2020+4.6%-9.2%-14.2%
Q2 2020
Q4 2019
Q2 2019
Q4 2018
Q2 2018
Q4 2017
Q2 2017
Q4 2016
Q2 2016
Q4 2015
Q2 2015
Q4 2014
Q2 2014
Q4 2013
Q2 2013
Q4 2012
Q4 2011
Q2 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro